Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases by Wenkuan Li, Jawaher Abdullah Alamoudi, Nagsen Gautam, Devendra Kumar, Macro Olivera, Yeongjin Gwon, Sandeep Mukgerjee, Yazen Alnouti

“…We have developed and validated the bile-acid liver disease complication (BALDC) model based on BA indices using logistic regression model, to predict the prognosis of cholestatic liver disease complications including ascites. …”
Get full text

Non-Alcoholic Fatty Liver Disease in Cardiac Patients with Overweight and Obesity by I. V. Logacheva, T. A. Ryazanova, V. R. Makarova, O. V. Surnina

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Prevalence and clinicopathological Spectrum of Auto-Immune Liver Diseases & Overlap syndrome by Annapoorani Varadarajan, Archana Rastogi, Rakhi Maiwall, Chhagan Bihari, Sherin Thomas, Vikrant Sood, Saggere Muralikrishna Shasthry

Subjects: Get full text

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota by R. V. Maslennikov, Yu. V. Evsyutina

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis by Melanie D Beaton

“…Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. …”
Get full text

Laboratory diagnostics of alcohol intoxication in patients with alcohol-induced liver disease by A. I. Pavlov, A. I. Khazanov

Get full text

Hyperparathyroidism in Patients with End-Stage Chronic Liver Disease (Clinical Observations) by A. A. Lavreniuk, A. N. Gorbacheva, E. E. Bibik, A. K. Eremkina, I. N. Tikhonov, N. G. Mokrysheva

Subjects: Get full text

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation by K. L. Raikhelson, M. V. Maevskaya, M. S. Zharkova, V. R. Grechishnikova, S. V. Okovityi, T. A. Deeva, N. V. Marchenko, M. К. Prashnova, V. T. Ivashkin

Subjects: “…steatotic liver disease…”
Get full text

Comparison Of ALT In Type 2 Diabetics with And Without Fatty Liver Disease by Kausar Malik, Faiza Batool, Lubna Meraj, Shazia Saddiq, Abrar Akbar, Hina Hanif Mughal

“…Conclusion: Fatty liver disease is more common in Type 2 diabetic patients with uncontrolled blood sugar. …”
Get full text

Peran Antioksidan pada Non Alcoholic Fatty Liver Disease (NAFLD) by Yusri Diane Jurnalis, Yorva Sayoeti, Elfitrimelly .

“…<p>Abstrak<br />Nonalcoholic Fatty Liver Disease (NAFLD) merupakan penyebab tersering penyakit hati kronik pada anak dan remaja diseluruh dunia. …”
Get full text

Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease by Yang Wang, Xiaohuan Yang, Sisi Wang

Subjects: Get full text

Clinical and morphological features of gastroduodenal pathology at alcohol-induced liver disease by I. V. Kozlova, M. A. Suschenko

Subjects: “…alcohol-induced liver disease…”
Get full text

Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease by Yuri Cho

Subjects: “…steatotic liver disease…”
Get full text

Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications by Ana-Maria Singeap, Carol Stanciu, Laura Huiban, Cristina Maria Muzica, Tudor Cuciureanu, Irina Girleanu, Stefan Chiriac, Sebastian Zenovia, Robert Nastasa, Catalin Sfarti, Camelia Cojocariu, Anca Trifan

“…Nonalcoholic fatty liver disease (NAFLD) has a rising prevalence worldwide. …”
Get full text

Electrical and Viscoelastic Parameters of Erythrocytes as a Part of Diagnostic Models for Differentiating Fatty Liver Disease of Mixed Genesis from Non-Alcoholic and Alcohol-Related Fatty Liver Disease by M. V. Kruchinina, M. F. Osipenko, M. V. Parulikova, A. A. Gromov

Subjects: “…fatty liver disease…”
Get full text

miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD) by Parthana Rani Sutradhar, Nahida Sultana, Afzalun Nessa

Get full text

Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control by Yun Gao, Xiushan Yin, Xiaomeng Ren

“…The chronic liver diseases will slowly develop into liver fibrosis, cirrhosis, and even liver cancer if no proper control is performed with high efficiency. …”
Get full text

Mechanisms of Action of Mesenchymal Stem Cells in Metabolic-Associated Fatty Liver Disease by Sitong Yi, Qingwei Cong, Ying Zhu, Qiumin Xu

“…Metabolic-associated fatty liver disease (MAFLD) is currently the most common chronic liver disease worldwide. …”
Get full text

Peroxisome Proliferator-Activated Receptor and Retinoic X Receptor in Alcoholic Liver Disease by Tommaso Mello, Simone Polvani, Andrea Galli

“…A growing number of new studies demonstrate that nuclear receptors are involved in the development of alcoholic liver disease (ALD). Ethanol metabolism and RXR/PPAR functions are tightly interconnected in the liver. …”
Get full text

Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021 by Gong Feng, Giovanni Targher, Christopher D. Byrne, Yusuf Yilmaz, Vincent Wai-Sun Wong, Cosmas Rinaldi Adithya Lesmana, Leon A. Adams, Jerome Boursier, George Papatheodoridis, Mohamed El-Kassas, Nahum Méndez-Sánchez, Silvia Sookoian, Laurent Castera, Wah-Kheong Chan, Feng Ye, Sombat Treeprasertsuk, Helena Cortez-Pinto, Hon Ho Yu, Won Kim, Manuel Romero-Gómez, Atsushi Nakajima, Khin Maung Win, Seung Up Kim, Adriaan G. Holleboom, Giada Sebastiani, Ponsiano Ocama, John D. Ryan, Monica Lupșor-Platon, Hasmik Ghazinyan, Mamun Al-Mahtab, Saeed Hamid, Nilanka Perera, Khalid A. Alswat, Qiuwei Pan, Michelle T. Long, Vasily Isakov, Man Mi, Marco Arrese, Arun J. Sanyal, Shiv Kumar Sarin, Nathalie Carvalho Leite, Luca Valenti, Philip N. Newsome, Hannes Hagström, Salvatore Petta, Hannele Yki-Järvinen, Jörn M. Schattenberg, Marlen I. Castellanos Fernández, Isabelle A. Leclercq, Gulnara Aghayeva, Abdel-Naser Elzouki, Ali Tumi, Ala I. Sharara, Asma Labidi, Faisal M. Sanai, Khaled Matar, Maen Al-Mattooq, Maisam Waid Akroush, Mustapha Benazzouz, Nabil Debzi, Maryam Alkhatry, Salma Barakat, Said A. Al-Busafi, John Rwegasha, Wah Yang, Agyei Adwoa, Christopher Kenneth Opio, Mohammadjavad Sotoudeheian, Yu Jun Wong, Jacob George, Ming-Hua Zheng

Subjects: “…Metabolic dysfunction-associated fatty liver disease…”
Get full text